Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters








Year range
1.
Rev. Col. Bras. Cir ; 29(6): 349-352, nov.-dez. 2002. tab
Article in Portuguese | LILACS | ID: lil-495360

ABSTRACT

OBJETIVOS: Avaliar a sobrevida dos pacientes portadores de carcinoma epidermóide do canal anal submetidos a cirurgia de resgate, por recidiva ou falha do tratamento radioquimioterápico inicial. MÉTODO: Análise retrospectiva dos pacientes portadores de carcinoma epídermóide do canal anal submetidos a cirurgia de resgate, de outubro de 1986 a setembro de 2000. RESULTADOS: Foram matriculados 93 pacientes portadores de carcinoma epidermóide do canal anal no período, e 21 (22,5 por cento) foram submetidos a resgate cirúrgico. Em 19 pacientes (91 por cento) foi realizada amputação abdominoperineal do reto (operação de Miles), em um paciente exenteração pélvica total e em um paciente excisão local. Não houve mortalidade operatória. A sobrevida média do grupo após resgate cirúrgico foi de 24 meses. CONCLUSÕES: Após recidiva e/ou falha da radioquimioterapia, a cirurgia de resgate é importante no controle locorregional do carcinoma epidermóide do canal anal.


BACKGROUND: Carcinoma of the anal canal is a rare neoplasia, the treatment of wich is based on chemoradiation Surgery is recommended alter treatment failure and recurrence. METHOD: A retrospective review from October 1986 to September 2000 of all patients who underwent salvage surgery alter chemoradiotherapy failure. Patients were reviewed as to time until recurrence and overall survival. RESULTS: Ninety-three patients with epidermoid carcinoma of the anal canal were reviewed. Twenty-one patients (22,5 percent) with residual or recurrent disease underwent salvage surgery. 19 patients (91 percent) underwent abdomino-perineal resection, 1 patient underwent pelvic exenteration and local resection was performed in 1 patient. There was no operative mortality. The overall survival was 24 months. CONCLUSIONS: Salvage surgical resection for anal canal carcinoma can be expected te yieid a number of survivors from residual/recurrent disease.

SELECTION OF CITATIONS
SEARCH DETAIL